Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical companies, such as the makers of Xarelto, possess a duty to ensure that their drugs are reasonably secure for use - and failure to accomplish so could be grounds for compensation. Our lawyers are operating challenging to acquire these hurt by the drug the compensation they may be entitled to.
Whilst bleeding is a common complication connected with anticoagulants, it has been alleged that Xarelto is far more dangerous than classic blood thinners since no antidote exists to reverse its blood-thinning effects. This indicates that, inside the occasion of an emergency, individuals might be at threat for irreversible bleeding troubles, including life-threatening internal and gastrointestinal hemorrhaging.
Should you or even a loved one particular suffered a severe bleeding event after taking Xarelto, you may have legal recourse. For much more data, get in touch with us right now to possess your case reviewed, totally free of charge.
Compensation Possibilitiesxarelto-compensation-photoThe plaintiffs
in these lawsuits are searching for compensation from Bayer and Janssen for previous and future health-related bills, lost wages, pain and suffering and, in situations of death, funeral costs. Additionally, they may be searching for punitive damages, which are normally awarded to punish the defendant and deter other organizations from acting similarly.
Why Are Lawsuits Being Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding inside the event of an emergency. Plaintiffs within the lawsuits allege critical and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a safe anticoagulant option.
Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user in the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing unsafe clotting.
Visit this read page
for more information on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.